Drug Profile
Research programme: GABA receptor modulators - Acorda Therapeutics
Alternative Names: GABAmideLatest Information Update: 29 Jul 2009
Price :
$50
*
At a glance
- Originator Neurorecovery
- Class
- Mechanism of Action GABA modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Epilepsy; Neurodegenerative disorders
Most Recent Events
- 05 Feb 2008 Acorda Therapeutics acquires ownership of GABAmide® product from Neurorecovery